Accelerate Diagnostics
AXDX
#10564
Rank
โ‚ฌ0.73 M
Marketcap
0,02920ย โ‚ฌ
Share price
0.00%
Change (1 day)
-98.05%
Change (1 year)

Accelerate Diagnostics (AXDX) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚ฌ72.65 Million

According to Accelerate Diagnostics's latest financial reports the company's total liabilities are โ‚ฌ72.65 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Accelerate Diagnostics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ46.36 M-43.02%
2022-12-31โ‚ฌ81.36 M-21.99%
2021-12-31โ‚ฌ0.10 B-17.89%
2020-12-31โ‚ฌ0.12 B0.35%
2019-12-31โ‚ฌ0.12 B13.23%
2018-12-31โ‚ฌ0.11 B1870.25%
2017-12-31โ‚ฌ5.67 M18.51%
2016-12-31โ‚ฌ4.78 M-16.99%
2015-12-31โ‚ฌ5.76 M84.1%
2014-12-31โ‚ฌ3.13 M126.03%
2013-12-31โ‚ฌ1.38 M
2012-07-31โ‚ฌ1.93 M91.77%
2011-07-31โ‚ฌ1 M-3.1%
2010-07-31โ‚ฌ1.04 M9.64%
2009-07-31โ‚ฌ0.94 M4.55%
2008-07-31โ‚ฌ0.9 M-1.26%
2007-07-31โ‚ฌ0.91 M6.33%
2006-07-31โ‚ฌ0.86 M-21.34%
2005-07-31โ‚ฌ1.09 M34.04%
2004-07-31โ‚ฌ0.82 M-8.31%
2003-07-31โ‚ฌ0.89 M-31.2%
2002-07-31โ‚ฌ1.3 M1.46%
2001-07-31โ‚ฌ1.28 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Thermo Fisher Scientific
TMO
โ‚ฌ44.54 B 61,210.23%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚ฌ5.67 B 7,706.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚ฌ25.27 B 34,687.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
โ‚ฌ2.54 B 3,398.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
โ‚ฌ0.27 B 284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bruker
BRKR
โ‚ฌ3.38 B 4,560.39%๐Ÿ‡บ๐Ÿ‡ธ USA